Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID).
Elessa D, Zhao LP, de Oliveira RD, Maslah N, Soret-Dulphy J, Verger E, Marcault C, Parquet N, Fenaux P, Adès L, Raffoux E, Giraudier S, Fain O, Cassinat B, Kiladjian JJ, Mekinian A, Benajiba L. Elessa D, et al. Among authors: maslah n. Leukemia. 2023 Aug;37(8):1741-1744. doi: 10.1038/s41375-023-01967-0. Epub 2023 Jul 11. Leukemia. 2023. PMID: 37433887 No abstract available.
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms.
Marcault C, Zhao LP, Maslah N, Verger E, Daltro de Oliveira R, Soret-Dulphy J, Cazaux M, Gauthier N, Roux B, Clappier E, Parquet N, Dosquet C, Réa D, Zini JM, Vainchenker W, Raffoux E, Giraudier S, Kiladjian JJ, Cassinat B, Benajiba L. Marcault C, et al. Among authors: maslah n. Blood. 2021 Nov 25;138(21):2142-2148. doi: 10.1182/blood.2020010402. Blood. 2021. PMID: 33945619 Free article. No abstract available.
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses.
Debureaux PE, Cassinat B, Soret-Dulphy J, Mora B, Verger E, Maslah N, Plessier A, Rautou PE, Ollivier-Hourman I, De Ledinghen V, Goria O, Bureau C, Siracusa C, Valla D, Giraudier S, Passamonti F, Kiladjian JJ. Debureaux PE, et al. Among authors: maslah n. Blood Adv. 2020 Aug 11;4(15):3708-3715. doi: 10.1182/bloodadvances.2020002414. Blood Adv. 2020. PMID: 32777065 Free PMC article.
26 results